Matisse Pharmaceuticals' Seed VC Round

Matisse Pharmaceuticals raised a round of funding on November 15, 2016.

Matisse Pharmaceuticals is a biotechnology company focused on the development of a treatment for sepsis and septic shock. The product under development (M6229) is based on a low coagulant fraction of …

Articles about Matisse Pharmaceuticals' Seed VC Round: